Internet Explorer is not supported. Please use a modern browser like Chrome, Firefox, or Edge to access this app.
Alopecia is an umbrella term for several types of hair loss. It can reflect the loss of hair follicles, hair shafts, or both. Different types of alopecia have different underlying causes, and thus will have different treatments. Your doctor prescribed the following medication based on your specific needs.
Your Medication May Contain One or More of the Following:
This medication causes a prolongation of the anagen hair phase and helps increase hair follicle size. You may experience at first a worsening of hair loss as the medication is helping shed the telogen phase of hair, but this should resolve within 4-6 weeks of continued treatment.(1) Studies have shown that topical minoxidil 5% used once daily for 24 weeks was well tolerated and promoted hair regrowth in male pattern hair loss, resulting in improved scalp coverage and increased hair density.(2)
DHT is the main culprit in male pattern hair loss. Finasteride inhibits an enzyme located in the hair follicle that converts testosterone to DHT, thereby decreasing the DHT in the scalp. It halts hair loss in 90% of patients, and partial hair regrowth occurs in 65% of those receiving finasteride.(3) Continued use is necessary to sustain regrowth.
Do not use this medication if:
Ask a doctor before use if you have heart disease
When using this product
Stop use and notify a clinician if you experience any of the following:
Side effects: in clinical trials, 3.8% of male patients noticed some form of sexual side effects (versus 2.1% of patients using the placebo), including less desire for sex, difficulty in achieving an erection, or a decrease in the amount of semen released during sex.(4)
Store at Controlled Room Temperature 20° to 25° C (68° to 77° F)
Information contained on this handout is provided as an informational aide and for reference use only. The content herein is not intended to be, act as, or replace medical advice or diagnosis for individual health conditions nor is it making evaluations as to the risks or benefits of particular compounded preparations. Please consult a licensed healthcare professional about diagnosis and treatment. Information and statements within this handout have not been evaluated by the Food and Drug Administration.
1. Piliang, MD. M, L. Pearson, MD R, Lowenstein, MD E, Scherger, MD, MPH J. Alopecia, First Consult. Clinical Key. https://www-clinicalkey-com. proxy1.athensams.net/#!/content/medical_topic/21-s2.0-1014848. Published 2011. Accessed July 10, 2018.
2. Hasanzadeh H, Nasrollahi S, Halavati N, Saberi M, Firooz A. Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction. Acta Dermatovenerologica Alpina Pannonica et Adriatica. 2016;25(3).
3. Kaufman KD, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89. doi: 10.1016/s0190-9622(98)70007-6. PMID: 9777765.
4. McClellan KJ, Markham A. Finasteride: a review of its use in male pattern hair loss. Drugs. 1999 Jan;57(1):111-26. doi: 10.2165/00003495-199957010-00014. PMID: 9951956.